US Biologic, INC.
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersMemphis, TN
US patents7
SAM.gov UEITBSGX6MQG877
CAGE code75F25
Incorporated inTN
- vaccines targeting
- animals
- animal-borne diseases
- Lyme disease
- public health
- human health
Named on the company’s own website, read JUL 29, 2026
Supplier designations
For Profit OrganizationManufacturer of Goods
Self-certified by the company in its SAM.gov registration
Patents
7 US patents granted 2020–2023, 6 of them in the five years to SEP 2025.
Pharmaceuticals 5Other special machines 2
- Oral vaccine for peste-des-petits-ruminants virusUS 11,850,280 · granted DEC 26, 2023
- Composition and method of an orally administered antimicrobial peptide vectored in a bacterial expression vehicleUS 11,814,628 · granted NOV 14, 2023
- Method to reduce tick population with a universal tick antigenUS 11,771,746 · granted OCT 3, 2023
- Time release application and monitoring system configured to prevent untargeted wildlife entry or disruptionUS 11,730,161 · granted AUG 22, 2023
- Method for reducing zoonotic infectious diseasesUS 11,576,868 · granted FEB 14, 2023
Newest 5 shown · Granted to US Biologic, INC · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| US Biologic, INC. | Memphis | TN | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.